Epileptic Encephalopathy research hub

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

This study is testing a new medicine, elsunersen, for young children and teenagers with a severe form of epilepsy called SCN2A-DEE. It aims to see if the medicine can reduce seizures and is safe. This trial is for children whose seizures started very early.